Diabetic neuropathy in sucrose-fed otsuka long-evans Tokushima fatty rats: Effect of an aldose reductase inhibitor, TAT

Life Sciences

Volumn 60, Issue 21, 1997, Pages 1847-1857

  Nakamura, Jiro ^a   Koh, Naoki ^a   Sakakibara, Fumihiko ^a   Hamada, Yoji ^a   Wakao, Takaaki ^a   Sasaki, Hiromitsu ^a   Mori, Koichi ^a   Nakashima, Eitaro ^a   Naruse, Keiko ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aldose reductase inhibitor; Coefficient of variance of R R interval; Diabetic neuropathy; Motor nerve conduction velocity; Nerve blood flow; Otsuka Long Evans Tokushima fatty rat; Platelet aggregation; Polyol pathway; Sucrose

Indexed keywords

ANIMALIA;

(5 (3 THIENYL)TETRAZOL 1 YL)ACETIC ACID; (5-(3-THIENYL)TETRAZOL-1-YL)ACETIC ACID; ALDEHYDE REDUCTASE; ANTITHROMBOCYTIC AGENT; ENZYME INHIBITOR; INSULIN; LIPID; POLYMER; POLYOL; SUCROSE; TETRAZOLE DERIVATIVE; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BLOOD FLOW; BODY WEIGHT; CHEMISTRY; DIABETIC NEUROPATHY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RAT; SCIATIC NERVE; THROMBOCYTE AGGREGATION; VASCULARIZATION;

ALDEHYDE REDUCTASE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INSULIN; LIPIDS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POLYMERS; RATS; REGIONAL BLOOD FLOW; SCIATIC NERVE; SUCROSE; TETRAZOLES; THIOPHENES;

EID: 0030631916     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00145-8     Document Type: Article

References (52)

1. A.A.F. SIMA, V. NATHANIEL, V. BRIL, T.A.J. McEWEN and D.A. GREENE, J Clin Invest 81 349-364 (1988).
2. A.A.F. SIMA, S. YAGIHASHI and D.A. GREENE, Diabetic Neuropathy, J. Ward, and Y. Goto (Eds), 17-28, John Wiley & Sons, Chichester (1990).
3. K. KAWANO, T. HIRASHIMA, S. MORI, Y. SAITOH, M. KUROSUMI and T. NATORI, Diabetes 41 1422-1428 (1992).
4. K. SHIMA, K. SHI, T. SANO, T. IWAMI, A. MIZUNO and Y. NOMA, Metabolism 42 971-977 (1993).
5. K. SHIMA, K. SHI, A. MIZUNO, K. ISHIDA and S. YOSHIMOTO, Diabetes Res Clin Pract 23 147-154 (1994).
6. K. ISHIDA, A. MIZUNO, Z. MIN, T. SANO and K. SHIMA, Metabolism 44 940-945 (1995).
7. D.A. GREENE, A.A.F. SIMA, M.J. STEVENS, E.L. FELDMAN and S.A. LATTIMER, Diabetes Care 15 1902-1925 (1992).
8. N. HOTTA and N. SAKAMOTO, The diabetes annual 5, K.G.M.M. Alberti, and L.P. Krall (Eds), 330-361, Elsevier, Amsterdam New York Oxford (1990).
9. D.R. TOMLINSON, G.B. WILLARS and A.L. CARRINGTON, Pharmac Ther 54 151-194 (1992).
10. D.A. GREENE, S.A. LATTIMER-GREENE and A.A.F. SIMA, Crit Rev Neurobiol 5 143-219 (1989).
11. X. ZHU and J. EICHBERG, J Neurochem 55 1087-1090 (1990).
12. J. NAKAMURA, M.A. DEL MONTE, D. SHEWACH, S.A. LATTIMER and D.A. GREENE, Am J Physiol 262 E417-426 (1992).
13. T.P. THOMAS, E.L. FELDMAN, J. NAKAMURA, K. KATO, M. LIEN, M.J. STEVENS and D.A. GREENE, Proc Natl Aca Sci USA 90 9712-9716 (1993).
14. N.E. CAMERON and M.A. COTTER, Diabetologia 35 1011-1019 (1992).
15. N.E. CAMERON and M.A. COTTER, Diabetes/Metab Rev 10 189-224 (1994).
16. B. TESFAMARIAN, J.J. PALACINO, R.M. WEISBROD and R.A. COHEN, J Cardiovasc Pharmacol 21 205-211 (1993).
17. M.J. STEVENS, J. DANANBERG, E.L. FELDMAN, S.A. LATTIMER, M. KAMIJO, T.P. THOMAS, H. SHINDO, A.A.F. SIMA and D.A. GREENE, J Cli Invet 94 853-859 (1994).
18. W.R. TIMPERLEY, J.D. WARD, F.E. PRESTON, T. DUCKWORTH and B.C. O'MALLEY, Diabetologia 12 237-243 (1976).
19. B.C. O'MALLEY, J.D. WARD, W.R. TIMPERLEY, N.R. PORTOR and F.E. PRESTON, Lancet ii 1274-1276 (1975).
20. J.A. COLWELL, P.V. HALUSHKA, K. SARJI, J. LEVIN, J. SAGEL and R.M.G. NAIR, Diabetes 25 (Suppl. 2) 826-831 (1976).
21. P.E. JENNINGS, K.J.C. DALLINGER, S. NIGHTINGALE and A.M. BARNETT, Diabetic Med 3 237-240 (1986).
22. A. ELDOR, S. MERIN, H. BAR-ON, Thrombos Res 13 703-714 (1978).
23. P.D. WINOCOUR, R.L. KINLOUGH-RATHBONE and J.F. MUSTARD, J Lab Clin Med 107 148-153 (1986).
24. P.D. WINOCOUR, R.L. KINLOUGH-RATHBONE and J.F. MUSTARD, J Lab Clin Med 107 154-158 (1986).
25. J.C. DUNBAR, L. REINHOLT, R.L. HENY and W. MAMMEN, Diabetes Res Clin Pract 9 265-272 (1990).
26. N. IIDA, R. IIDA, N. TAKEYAMA and T. TANAKA, Biochem Mol Biol Int 30 177-185 (1993).
27. S. INUKAI, M. AGATA, M. SATO, A. NAITO, H. MATSUKAWA and M. GOTO, Jpn J Pharmacol 61 221-227 (1993).
28. N. HOTTA, H. KAKUTA, H. FUKASAWA, N. KOH, F. SAKAKIBARA, J. NAKAMURA, Y. HAMADA, T. WAKAO, T. HARA, K. MORI, K. NARUSE, E. NAKASHIMA, S. INUKAI and N. SAKAMOTO, Diabetes Res Clin Pract 27 107-117 (1995).
29. T. MIYOSHI and I. GOTO, Electroencephalogr Clin Neurophysiol 35 125-131 (1973).
30. N. HOTTA, H. KAKUTA, H. FUKASAWA, N. KOH, F. SAKAKIBARA, H. KOMORI and N. SAKAMOTO, Diabetes 41 587-591 (1992).
31. N. HOTTA, J. NAKAMURA, H. KAKUTA, H. FUKASAWA, N. KOH, F. SAKAKIBARA, K. MORI and N. SAKAMOTO, J Diab Comp 9 133-139 (1995).
32. N.G. ARDLIE, M.A. PACKHAM and J.F. MUSTARD, Brit J Haemat 19 7-17 (1970).
33. T. HARA, J NAKAMURA, N. KOH, F. SAKAKIBARA, Y. HAMADA, H. SASAKI, K. NARUSE, E, NAKASHIMA, N, TAKEUCHI, S. INUKAI and N. HOTTA, J Lab Clin Med 126 541-547 (1995).
34. K. MIZUNO, N. KATO, A. MATSUBARA, K. NAKANO and M. KURONO, Metabolism 41 1081-1086 (1992).
35. A.A.F. SIMA, T. BRISMAR and S. YAGIHASHI, Diabetic neuropathy, P.J. Dyck, P.K. Thomas, A.K. Asbury, A.I. Winegrad, and D. Porte Jr (Eds) 253-259, Saunders, Philadelphia (1987).
36. S. YAGIHASHI, A. TONOSAKI, K. YAMADA, M. KAKIZAKI and Y. GOTO, Tohoku J Exp Med 138 39-48 (1982).
37. S. YAGIHASHI, R, WADA, M. KAMIJO and K. NAGAI, Lab Invest 68 296-307 (1993).
38. N. HOTTA, H. KAKUTA, H. FUKASAWA, M. KIMURA, N. KOH, M. IIDA, H. TERASHIMA, T. MORIMURA and N. SAKAMOTO, Diabetologia 28 176-180 (1985).
39. D. PAPACHRISTODOULOU and H. HEATH, Exp Eye Res 25 371-384 (1977).
40. H. HEATH and Y.C. HAMLETT, Diabetologia 12 43-46 (1976).
41. A.M. COHEN and E. ROSENMANN, Diabetologia 7 25-31 (1971).
42. H.C. POWELL, M.L. COSTELLO and R.R. MYERS, J Neuropathol Exp Neurol 40 613-624 (1981).
43. J. SREDY, B.R. FLAM and D.R. SAWICKI, Proc Soc Exp Biol Med 197 135-143 (1991).
44. J.R. WILLIAMSON, K. CHANG, M. FRANGOS, K.S. HASAN, Y. IDO, T. KAWAMURA, J.R. NYENGAARD, M. VAN DEN ENDEN, C. KILO and R.G. TILTON, Diabetes 42 801-813 (1993).
45. D.W. ZOCHODNE and L.T. HO, Can J Physiol Pharmacol 70 651-659 (1992).
46. R.G. TILTON, K. CHANG, G. PUGLIESE, D.M. EADES, M.A. PROVINCE, W.R. SHERMAN, C. KILO and J.R. WILLIAMSON, Diabetes 38 1258-1270 (1989).
47. G. PUGLIESE, R.G. TILTON, A. SPEEDY, E. SANTARELLI, D.M. EADES, M.A. PROVINCE, C. KILO, W.R. SHERMAN and J.R. WILLIAMSON, Diabetes 39 312-322 (1990).
48. J.A. COLWELL, P.D. WINOCOUR and P.V. HALUSHKA, Diabetes 32 (Suppl. 2) 14-19 (1983).
49. E. ERNST and A. MATRAI, Diabetes 35 1412-1415 (1986).
50. C. ROBEY, A. DASMAHAPATRA, M.P. COHEN and S. AOAREZ, Diabetes 36 1010-1013 (1987).
51. G.D.O. LOWE, I.M. GHAFOUR, J.J.F. BELCH, C.D. FORBES, W.S. FOULD and A.C. MACIUSH, Diabetes Res 3 67-70 (1986).
52. P.D. WINOCOUR, M. LOPES-VIRELLA, M. LAIMINS and J.A. COLWELL, J Lab Clin Med 102 795-804 (1983).